Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

ER - Ad-hoc-Meldung gemäß Art. 17 MAR in Verbindung mit § 4 Abs. 1 S. 1 Nr. 1a WpAV

Company: Biofrontera AG Date: 2024-07-21 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.html) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

  Finanzbericht: 34598699

scrollen

|     |     |
| --- | --- | 
| Betreff: | Ad-hoc-Meldung gemäß Art. 17 MAR in Verbindung mit § 4 Abs. 1 S. 1 Nr. 1a WpAV |
| Schlagworte: | legal matter / amendment of forecast / budget figures / forecast |
| Eintritt der Insiderinformationen: | 21.07.2024 |
| Ergänzende Angaben: | Biofrontera AG: Legal dispute on import in the USA and resulting revised outlook |

  

Angaben zum Inhalt:

scrollen

|     |     |
| --- | --- | 
| Inhalt der Ad-Hoc-Mitteilung: | Biofrontera AG: Legal dispute on import in the USA and resulting revised outlook<br><br>Leverkusen, Germany (pta008/21.07.2024/14:45 UTC+2) - Biofrontera AG has been sued by a USA competitor with the argument that Biofrontera infringes some competitors' lamps patents.<br><br>The competitor has filed two different processes, one for two patent infringements in front of the district court, and a second one before the ITC (International Trade Commission), aiming to prohibit the import in the USA of Biofrontera XL Lamp.<br><br>Biofrontera has requested initial legal advice and is currently in the process of evaluating its legal position. Biofrontera AG and its subsidiaries have signed a jointly defense agreement with Biofrontera Inc, to share legal expenses.<br><br>Costs for the ITC legal proceedings are expected to amount to US$5 million, to be shared between to two companies. The outlook for the business year 2024 needs to be revised as a result. Currently the company is about to establish the effects and will inform about a new outlook once there is more clarity about the situation.<br><br>Emitter: Biofrontera AG  <br><br>Adresse: Hemmelrather Weg 201, 51377 Leverkusen  <br><br>Country: Germany  <br><br>Contact person: Investor Relations  <br><br>Tel.: +49 (0) 214 87 63 20  <br><br>Email: ir@biofrontera.com  <br><br>Website: www.biofrontera.com  <br><br>ISIN(s): DE000A4BGGM7 (Aktie)  <br><br>Exchanges: Regulated Market in Dusseldorf, Regulated Market in Frankfurt, Free Market in Berlin, Free Market in Munich, Free Market in Stuttgart, Open Market in Tradegate  <br><br>Quelle: https://www.pressetext.com/news/20240721008 |

  

Angaben zum Emittenten:

scrollen

|     |     |
| --- | --- | 
| Name: | Biofrontera AG |
| Adresse: | Hemmelrather Weg 201, 51377 Leverkusen |
| E-Mail-Adresse: | ir@biofrontera.com |
| Internet-Adresse:: | http://www.biofrontera.com |
| ISIN: | DE000A4BGGM7 (Aktie) |
| Handelsplätze: | Regulated Market in Dusseldorf, Regulated Market in Frankfurt, Free Market in Berlin, Free Market in Munich, Free Market in Stuttgart, Open Market in Tradegate |

  

Angaben zur Pflichtmitteilung:

scrollen

|     |     |
| --- | --- | 
| Veröffentlichung in elektronisch betriebenen Informationsverbreitungssystem: | pressetext, published over Bloomberg, Dow Jones Newswires and Thomson Reuters |
| Pflichtveröffentlichung am: | 21.07.2024 |
| Uhrzeit der Veröffentlichung: | 14:45:00 |
| Pflichtveröffentlichung in/über: | pressetext, published over Bloomberg, Dow Jones Newswires and Thomson Reuters |
| Pflichtveröffentlichung am: | 2024-07-21 |
| Sprachen der Veröffentlichung: | Englisch |

Unlock Europe's Largest Financial Database—Free

Get instant access to over 2.8M filings from 8,970 companies across 44 markets. No cost. No hassle. Just results.